Identifying new diseases and their causes: The dilemma of illnesses in Gulf War veterans

Military Medicine

Volumn 168, Issue 3, 2003, Pages 186-193

  Gardner, John W ^a,c   Gibbons, Robert V ^a   Hooper, Tomoko I ^a   Cunnion, Stephen O ^a   Kroenke, Kurt ^b   Gackstetter, Gary D ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Regenstrief Institute for Health Care   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; THALIDOMIDE; VINYL CHLORIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADENOCARCINOMA; ALGORITHM; ANGIOSARCOMA; ARTICLE; CARDIOVASCULAR RISK; CHRONIC FATIGUE SYNDROME; CIGARETTE SMOKING; CLINICAL FEATURE; DEATH; DISEASE COURSE; ECOTOXICITY; EPIDEMIC; FIBROMYALGIA; HANTAVIRUS PULMONARY SYNDROME; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY TEST; LEGIONNAIRE DISEASE; LIVER SARCOMA; MEDICAL CARE; MULTIPLE CHEMICAL SENSITIVITY; OUTPATIENT; PAIN ASSESSMENT; PERSIAN GULF SYNDROME; PHOCOMELIA; PRENATAL EXPOSURE; RHEUMATIC FEVER; SEXUAL BEHAVIOR; SOLDIER; STAPHYLOCOCCUS AUREUS; TOXIC SHOCK SYNDROME; VAGINA CARCINOMA; VIRUS LOAD;

EID: 0037339093     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/168.3.186     Document Type: Article

References (106)

1. Helmkamp JC: United States military casualty comparisons during the Persian Gulf War. J Occup Med 1994; 36: 609-15.
2. Writer JV, DeFraites RF, Brundage JF: Comparative mortality among U.S. military personnel in the Persian Gulf region and worldwide during Operations Desert Shield and Desert Storm. JAMA 1996; 275: 118-21.
3. Kang HK, Bullman TA: Mortality among U.S. veterans of the Persian Gulf War. N Engl J Med 1996; 335: 1498-504.
4. Gray GC, Coate BD, Anderson CM, et al: The postwar hospitalization experience of U.S. veterans of the Persian Gulf War. N Engl J Med 1996; 335: 1505-13.
5. Cowan DN, DeFraites RF, Gray GC, et al: The risk of birth defects among children of Persian Gulf War veterans. N Engl J Med 1997; 336: 1650-6.
6. Joseph SC. Comprehensive Clinical Evaluation Program Team: A comprehensive clinical evaluation of 20,000 Persian Gulf War veterans. Milit Med 1997; 162: 149-55.
7. Kroenke K, Koslowe P, Roy M: Symptoms in 18,495 Persian Gulf War veterans: latency of onset and lack of association with self-reported exposures. J Occup Environ Med 1998; 40: 520-8.
8. Kroenke K, Mangelsdorff AD: Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med 1989; 86: 262-6.
9. Kroenke K, Price RK: Symptoms in the community: prevalence, classification, and psychiatric comorbidity. Arch Intern Med 1993; 153: 2474-80.
10. Kroenke K, Arrington ME, Mangelsdorff AD: The prevalence of symptoms in medical outpatients and the adequacy of therapy. Arch Intern Med 1990; 150: 1685-9.
11. Kroenke K, Spitzer RL, Williams JBW, et al: Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994; 3: 774-9.
12. Marple RL, Kroenke K, Lucey CR, et al: Concerns and expectations in patients presenting with physical complaints: frequency, physician perceptions and actions, and 2-week outcome. Arch Intern Med 1997; 157: 1482-8.
13. Reidenberg MM, Lowenthal DT: Adverse nondrug reactions. N Engl J Med 1968; 279: 678-9.
14. Taussig HB: A study of the German outbreak of phocomelia: the thalidomide syndrome. JAMA 1962; 180: 1106-14.
15. Smithells RW, Leck I: The incidence of limb and ear defects since the withdrawal of thalidomide. Lancet 1963: 1095-7.
16. Herbst AL, Scully RE: Adenocarcinoma of the vagina in adolescence: a report of 7 cases including 6 clear-cell carcinomas (so-called mesonephromas). Cancer 1970; 25: 745-57.
17. Herbst AL, Ulfelder H, Poskanzer DC: Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971; 284: 878-81.
18. Creech J, Johnson MN, Block B: Angiosarcoma of the liver among polyvinyl chloride workers - Kentucky. Morb Mortal Wkly Rep 1974; 23: 49-50.
19. Creech J, Johnson MN: Angiosarcoma of liver in the manufacture of polyvinyl chloride. J Occup Med 1974; 16: 150-1.
20. Monson RR, Peters JM, Johnson MN: Proportional mortality among vinyl-chloride workers. Lancet 1974; 2: 397-8.
21. Waxweiler RJ, Stringer W, Wagoner JK, et al: Neoplastic risk among workers exposed to vinyl chloride. Ann NY Acad Sci 1976; 271: 40-8.
22. Todd J, Fishaut M, Kapral F, et al: Toxic-shock syndrome associated with phage-group-1 Staphylococci. Lancet 1978; 2: 1116-8.
23. Centers for Disease Control: Toxic-shock syndrome: United States. Morb Mortal Wkly Rep 1980; 29: 229-30.
24. Centers for Disease Control: Follow-up on toxic-shock syndrome. Morb Mortal Wkly Rep 1980; 29: 441-5.
25. Shands KN, Schmid GP, Dan BB, et al: Toxic-shock syndrome in menstruating women. N Engl J Med 1980; 303: 1436-42.
26. Berkley SF, Hightower AW, Broome CV, et al: The relationship of tampon characteristics to menstrual toxic shock syndrome. JAMA 1987; 258: 917-20.
27. Broome CV: Epidemiology of toxic shock syndrome in the United States: overview. Rev Infect Dis 1989; 11(Suppl 1): S14-21.
28. Doll R, Hill AB: Smoking and carcinoma of the lung: preliminary report. Br Med J 1950; 1: 739-48.
29. Doll R, Hill AB: Lung cancer and other causes of death in relation to smoking: a second report on the mortality of British doctors. Br Med J 1956; 2: 1071-81.
30. Public Health Service: Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Health Service. PHS publication no. 1103. Washington, DC, U.S. Government Printing Office, 1964.
31. Fraser DW, Tsai TR, Orenstein W, et al: Legionnaires' disease: description of an epidemic of pneumonia. N Engl J Med 1977; 297: 1189-97.
32. McDade JE, Shepard CC, Fraser DW, et al: Legionnaire's disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med 1977; 297: 1197-203.
33. Cordes LG, Fraser DW, Skaliy P, et al: Legionnaires' disease outbreak at an Atlanta, Georgia country club: evidence for spread from an evaporative condenser. Am J Epidemiol 1980; 111: 425-31.
34. Terranova W, Cohen ML, Fraser DW: 1974 outbreak of Legionnaires' disease diagnosed in 1977. Lancet 1978; 2: 122-4.
35. Glick TH, Gregg MB, Berman B, et al: Pontiac fever: an epidemic of unknown etiology in a health department: I. Clinical and epidemiologic aspects. Am J Epidemiol 1978; 107: 149-60.
36. Berkelman RL: Emerging infectious diseases in the United States, 1993. J Infect Dis 1994; 170: 272-7.
37. Hughes JM, Peters CJ, Cohen ML, et al: Hantavirus pulmonary syndrome: an emerging infectious disease. Science 1993; 262: 850-1.
38. Centers for Disease Control and Prevention: Outbreak of acute illness - southwestern United States, 1993. Morb Mortal Wkly Rep 1993; 42: 421-4.
39. Centers for Disease Control and Prevention: Update: outbreak of hantavirus infection - southwestern United States, 1993. Morb Mortal Wkly Rep 1993; 42: 477-9.
40. Public Health Service: Smoking and Health; Report of the Surgeon General. DHEW publication no. (PHS) 79-5006. Washington, DC, U.S. Government Printing Office, 1979.
41. Public Health Service: The Health Consequences of Smoking: Cardiovascular Disease: A Report of the Surgeon General. DHHS publication no. (PHS) 84-50204. Washington, DC, U.S. Government Printing Office, 1983.
42. Jones TD: The diagnosis of rheumatic fever. JAMA 1944; 126: 481-4.
43. Markowitz M, Gerber MA: The Jones criteria for guidance in the diagnosis of rheumatic fever: another perspective. Arch Pediatr Adolesc Med 1995; 149: 725-6.
44. Centers for Disease Control: Pneumocystis pneumonia - Los Angeles. Morb Mortal Wkly Rep 1981; 30: 250-2.
45. Centers for Disease Control: Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New York City and California. Morb Mortal Wkly Rep 1981; 30: 305-8.
46. Centers for Disease Control: A cluster of Kaposi's sarcoma and Pneumocystis carinii pneumonia among homosexual male residents of Los Angeles and Orange counties. California. Morb Mortal Wkly Rep 1982; 31: 305-7.
47. Centers for Disease Control: Update on acquired immune deficiency syndrome (AIDS) - United States. Morb Mortal Wkly Rep 1982; 31: 507-14.
48. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, third edition. Washington, DC, American Psychiatric Association, 1980.
49. Steere AC, Malawista SE, Snydman DR, et al: Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977; 20: 7-17.
50. Steere AC: Lyme disease. N Engl J Med 1989; 321: 586-96.
51. Schappert SM: National Ambulatory Medical Care Survey: 1994 Summary. Advance data no. 273. Hyattsville, MD. National Center for Health Statistics. 1996,
52. Goldenberg DL: Fibromyalgia and other chronic fatigue syndromes: is there evidence for chronic viral disease? Semin Arthritis Rheum 1988; 18: 111-20.
53. Yunus MB, Masi AT, Aldag JC: A controlled study of primary fibromyalgia syndrome: clinical features and association with other functional syndromes. J Rheumatol 1989; 16(Suppl 19): 62-71.
54. Hudson JI, Goldenberg DL, Pope HG Jr, et al: Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992; 92: 363-7.
55. Buchwald D, Garrity D: Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 1994; 154: 2049-53.
56. Kroenke K, Spitzer RL, deGruy FV III, et al: Multisomatoform disorder: an alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry 1997; 54: 352-8.
57. Smythe HA, Moldofsky H: Two contributions to understanding of the "fibrositis" syndrome. Bull Rheum Dis 1977; 28: 928-31.
58. Powers R: Fibromyalgia: an age-old malady begging for respect. J Gen Intern Med 1993; 8: 93-105.
59. Wolfe F, Smythe HA, Yunus MB, et al: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 160-72.
60. Bohr TW: Fibromyalgia syndrome and myofascial pain syndrome: do they exist? Neurol Clin 1995; 13: 365-84.
61. Holmes GP, Kaplan JE, Gantz NM, et al: Chronic fatigue syndrome: a working case definition. Ann Int Med 1988; 108: 387-9.
62. Fukuda K, Straus SE, Hickie I, et al: The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953-9.
63. Swartz MN: The chronic fatigue syndrome - one entity or many? N Engl J Med 1988; 319: 1726-8.
64. Manu P, Lane TJ, Matthews DA: The pathophysiology of chronic fatigue syndrome: confirmations, contradictions, and conjectures. Int J Psychiatry Med 1992; 22: 397-408.
65. McKenzie R, Straus SE: Chronic fatigue syndrome. Adv Intern Med 1995; 40: 119-53.
66. Bates DW, Buchwald D, Lee J, et al: A comparison of case definitions of chronic fatigue syndrome. Clin Infect Dis 1994; 18(Suppl 1): S11-15.
67. Cullen MR (editor): The Worker with multiple chemical sensitivities: an overview. Occup Med 1987; 2: 655-804.
68. Bronstein AC: Multiple chemical sensitivities - new paradigm needed. J Toxicol Clin Toxicol 1995; 33: 93-4.
69. Gots RE: Multiple chemical sensitivities - public policy. J Toxicol Clin Toxicol 1995; 33: 111-3.
70. Richter E: Multiple chemical sensitivity: respect the observations ... suspect the interpretations? Arch Environ Health 1993; 48: 366-7.
71. Kurt TL: Multiple chemical sensitivities: a syndrome of pseudotoxicity manifest as exposure perceived symptoms. J Toxicol Clin Toxicol 1995; 33: 101-5.
72. Simon GE, Daniell W, Stockbridge H, et al: Immunologic, psychological, and neuropsychological factors in multiple chemical sensitivity: a controlled study. Ann Intern Med 1993; 119: 97-103.
73. American Academy of Allergy and Immunology: Position statements: clinical ecology. J Allerg Clin Immunol 1986; 78: 269-71.
74. American College of Physicians: Position paper: clinical ecology. Ann Intern Med 1989; 111: 168-78.
75. American Medical Association Council on Scientific Affairs: Clinical ecology. JAMA 1992; 268: 3465-7.
76. Hyams KC: Developing case definitions for symptom-based conditions: the problem of specificity. Epidemiol Rev 1998; 20: 148-56.
77. Aronowitz RA: From myalgic encephalitis to yuppie flu: a history of chronic fatigue syndromes. In: Framing Disease: Studies in Cultural History, pp 155-81. Edited by Rosenberg CE, Golden J. New Brunswick, NJ. Rutgers University Press, 1992.
78. Aronowitz RA: Making Sense of Illness: Science, Society, and Disease. New York, NY. Cambridge University Press, 1998.
79. Simon G, Gater R, Kisely S, et al: Somatic symptoms of distress: an international primary care study. Psychosom Med 1996; 58: 481-8.
80. Mathew RJ, Weinman ML, Mirabi M: Physical symptoms of depression. Br J Psychiatry 1981; 139: 293-6.
81. Yunus M, Masi AT, Calabro JJ, et al: Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981; 11: 151-71.
82. Goldenberg DL: Fibromyalgia syndrome: an emerging but controversial condition. JAMA 1987; 257: 2782-7.
83. Wolfe F, Cathey MA: Prevalence of primary and secondary fibrositis. J Rheumatol 1983; 10: 965-8.
84. Komaroff AL, Buchwald D: Symptoms and signs of chronic fatigue syndrome. Rev Infect Dis 1991; 13(Suppl 1): S8-11.
85. Fukuda K, Nisenbaum R, Stewart G, et al: Chronic multisymptom illness affecting Air Force veterans of the Gulf War. JAMA 1998; 280: 981-8.
86. The Iowa Persian Gulf Study Group: Self-reported illness and health status among Gulf War veterans: a population-based study. JAMA 1997; 277: 238-45.
87. Stretch RH, Bliese PD, Marlowe DH, et al: Physical health symptomatology of Gulf War-era service personnel from the states of Pennsylvania and Hawaii. Milit Med 1995; 160: 131-6.
88. Hammond EC: Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women. Am J Public Health 1964; 54: 11-23.
89. Hudson RP: Theory and therapy: ptosis, stasis, and autointoxication. Bull Hist Med 1989; 63: 392-413.
90. Department of Defense: Report of the Defense Science Board Task Force on the Persian Gulf War Health Effects. Washington, DC, Office of the Under Secretary of Defense for Acquisition and Technology, 1994.
91. National Institute of Health Technology Assessment Workshop Panel: The Persian Gulf experience and health. JAMA 1994; 272: 391-5.
92. Institute of Medicine: Health Consequences of Service during the Persian Gulf War: Initial Findings and Recommendations for Immediate Action. Washington, DC, National Academy Press, 1995.
93. Institute of Medicine: Health Consequences of Service during the Persian Gulf War: Recommendations for Research and Information Systems. Washington, DC, National Academy Press, 1996.
94. Institute of Medicine: Evaluation of the U.S. Department of Defense Persian Gulf Comprehensive Clinical Evaluation Program. Washington, DC. National Academy Press, 1996.
95. Department of Veterans Affairs: VA Persian Gulf Expert Scientific Committee Report, February 19, 1996. Washington, DC, Department of Veterans Affairs, 1996.
96. Presidential Advisory Committee on Gulf War Veterans' Illnesses: Final Report. Washington, DC, Government Printing Office, 1996.
97. Hyams KC, Wignall FS, Roswell R: War syndromes and their evaluation: from the U.S. Civil War to the Persian Gulf War. Ann Intern Med 1996; 125: 398-405.
98. Cleland LG: "RSI": a model of social iatrogenesis. Med J Aust 1987; 147: 236-9.
99. Hocking B: Epidemiological aspects of "repetition strain injury" in Telecom Australia. Med J Australia 1987; 147: 218-22.
100. Boss LP: Epidemic hysteria: a review of the published literature. Epidemiol Rev 1997; 19: 233-43.
101. Schnabel J: The real causes of "Gulf War Syndrome." Washington Post, November 15, 1996, p A31.
102. Wegman DH, Woods NF, Bailar JC: Invited commentary: how would we know a Gulf War Syndrome if we saw one? Am J Epidemiol 1997; 146: 704-11.
103. Hyams KC, Roswell RH: Resolving the Gulf War Syndrome question. Am J Epidemiol 1998; 148: 339-42.
104. Joellenbeck LM, Landrigan PJ, Larson EL. Commentary: Gulf War veterans' illnesses: a case study in causal inference. Environ Res 1998; 79: 71-81.
105. Rothman KJ (editor): Causal Inference. Chestnut Hill, MA. Epidemiology Resources, 1988.
106. Lashof JC, Cassells JS: Illness among Gulf War veterans: risk factors, realities, and future research. JAMA 1998; 280: 1010-1.